Author

Tao-Bo Luo

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Neoadjuvant QL1706 plus chemotherapy in patients with stage II–IIIB squamous non-small cell lung cancer: study protocol for a prospective, single-arm, multicentre phase II trial

Abstract Introduction Lung squamous cell carcinoma is a subtype of non-small cell lung cancer (NSCLC) and its biological characteristics or treatment responses might differ from non-squamous NSCLC. Although neoadjuvant immunotherapy combined with chemotherapy has become the guideline-recommended treatment for resectabl...

Ying Jin, Tao-Bo Luo, Jia-Dong Chu et al. · BMJ Open · 0 citations

Review Open access Oct 2026

KRAS Mutations in Cancers: From Undruggable Dilemma to Precision Medicine

KRAS is one of the most frequently altered oncogenic drivers across human solid tumors and has long represented a central challenge in precision oncology. The clinical success of covalent KRAS G12C inhibitors has transformed a historically “undruggable” target into a tractable therapeutic class, but durable benefit rem...

Jia-Ying Cai, Yi-Min Wu, Xing Jia et al. · MedComm · 0 citations